Cargando…

Endocytosis and Recycling of the HIV Coreceptor Ccr5

The chemokine receptor CCR5 is a cofactor for the entry of R5 tropic strains of human immunodeficiency viruses (HIV)-1 and -2 and simian immunodeficiency virus. Cells susceptible to infection by these viruses can be protected by treatment with the CCR5 ligands regulated on activation, normal T cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Signoret, Nathalie, Pelchen-Matthews, Annegret, Mack, Matthias, Proudfoot, Amanda E.I., Marsh, Mark
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190598/
https://www.ncbi.nlm.nih.gov/pubmed/11121442
_version_ 1782146836624048128
author Signoret, Nathalie
Pelchen-Matthews, Annegret
Mack, Matthias
Proudfoot, Amanda E.I.
Marsh, Mark
author_facet Signoret, Nathalie
Pelchen-Matthews, Annegret
Mack, Matthias
Proudfoot, Amanda E.I.
Marsh, Mark
author_sort Signoret, Nathalie
collection PubMed
description The chemokine receptor CCR5 is a cofactor for the entry of R5 tropic strains of human immunodeficiency viruses (HIV)-1 and -2 and simian immunodeficiency virus. Cells susceptible to infection by these viruses can be protected by treatment with the CCR5 ligands regulated on activation, normal T cell expressed and secreted (RANTES), MIP-1α, and MIP-1β. A major component of the mechanism through which chemokines protect cells from HIV infection is by inducing endocytosis of the chemokine receptor. Aminooxypentane (AOP)-RANTES, an NH(2)-terminal modified form of RANTES, is a potent inhibitor of infection by R5 HIV strains. AOP-RANTES efficiently downmodulates the cell surface expression of CCR5 and, in contrast with RANTES, appears to prevent recycling of CCR5 to the cell surface. Here, we investigate the cellular basis of this effect. Using CHO cells expressing human CCR5, we show that both RANTES and AOP-RANTES induce rapid internalization of CCR5. In the absence of ligand, CCR5 shows constitutive turnover with a half-time of 6–9 h. Addition of RANTES or AOP-RANTES has little effect on the rate of CCR5 turnover. Immunofluorescence and immunoelectron microscopy show that most of the CCR5 internalized after RANTES or AOP-RANTES treatment accumulates in small membrane-bound vesicles and tubules clustered in the perinuclear region of the cell. Colocalization with transferrin receptors in the same clusters of vesicles indicates that CCR5 accumulates in recycling endosomes. After the removal of RANTES, internalized CCR5 recycles to the cell surface and is sensitive to further rounds of RANTES-induced endocytosis. In contrast, after the removal of AOP-RANTES, most CCR5 remains intracellular. We show that these CCR5 molecules do recycle to the cell surface, with kinetics equivalent to those of receptors in RANTES-treated cells. However, these recycled CCR5 molecules are rapidly reinternalized. Our results indicate that AOP-RANTES–induced changes in CCR5 alter the steady-state distribution of the receptor and provide the first evidence for G protein–coupled receptor trafficking through the recycling endosome compartment.
format Text
id pubmed-2190598
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21905982008-05-01 Endocytosis and Recycling of the HIV Coreceptor Ccr5 Signoret, Nathalie Pelchen-Matthews, Annegret Mack, Matthias Proudfoot, Amanda E.I. Marsh, Mark J Cell Biol Original Article The chemokine receptor CCR5 is a cofactor for the entry of R5 tropic strains of human immunodeficiency viruses (HIV)-1 and -2 and simian immunodeficiency virus. Cells susceptible to infection by these viruses can be protected by treatment with the CCR5 ligands regulated on activation, normal T cell expressed and secreted (RANTES), MIP-1α, and MIP-1β. A major component of the mechanism through which chemokines protect cells from HIV infection is by inducing endocytosis of the chemokine receptor. Aminooxypentane (AOP)-RANTES, an NH(2)-terminal modified form of RANTES, is a potent inhibitor of infection by R5 HIV strains. AOP-RANTES efficiently downmodulates the cell surface expression of CCR5 and, in contrast with RANTES, appears to prevent recycling of CCR5 to the cell surface. Here, we investigate the cellular basis of this effect. Using CHO cells expressing human CCR5, we show that both RANTES and AOP-RANTES induce rapid internalization of CCR5. In the absence of ligand, CCR5 shows constitutive turnover with a half-time of 6–9 h. Addition of RANTES or AOP-RANTES has little effect on the rate of CCR5 turnover. Immunofluorescence and immunoelectron microscopy show that most of the CCR5 internalized after RANTES or AOP-RANTES treatment accumulates in small membrane-bound vesicles and tubules clustered in the perinuclear region of the cell. Colocalization with transferrin receptors in the same clusters of vesicles indicates that CCR5 accumulates in recycling endosomes. After the removal of RANTES, internalized CCR5 recycles to the cell surface and is sensitive to further rounds of RANTES-induced endocytosis. In contrast, after the removal of AOP-RANTES, most CCR5 remains intracellular. We show that these CCR5 molecules do recycle to the cell surface, with kinetics equivalent to those of receptors in RANTES-treated cells. However, these recycled CCR5 molecules are rapidly reinternalized. Our results indicate that AOP-RANTES–induced changes in CCR5 alter the steady-state distribution of the receptor and provide the first evidence for G protein–coupled receptor trafficking through the recycling endosome compartment. The Rockefeller University Press 2000-12-11 /pmc/articles/PMC2190598/ /pubmed/11121442 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Original Article
Signoret, Nathalie
Pelchen-Matthews, Annegret
Mack, Matthias
Proudfoot, Amanda E.I.
Marsh, Mark
Endocytosis and Recycling of the HIV Coreceptor Ccr5
title Endocytosis and Recycling of the HIV Coreceptor Ccr5
title_full Endocytosis and Recycling of the HIV Coreceptor Ccr5
title_fullStr Endocytosis and Recycling of the HIV Coreceptor Ccr5
title_full_unstemmed Endocytosis and Recycling of the HIV Coreceptor Ccr5
title_short Endocytosis and Recycling of the HIV Coreceptor Ccr5
title_sort endocytosis and recycling of the hiv coreceptor ccr5
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190598/
https://www.ncbi.nlm.nih.gov/pubmed/11121442
work_keys_str_mv AT signoretnathalie endocytosisandrecyclingofthehivcoreceptorccr5
AT pelchenmatthewsannegret endocytosisandrecyclingofthehivcoreceptorccr5
AT mackmatthias endocytosisandrecyclingofthehivcoreceptorccr5
AT proudfootamandaei endocytosisandrecyclingofthehivcoreceptorccr5
AT marshmark endocytosisandrecyclingofthehivcoreceptorccr5